Sedgefield, United Kingdom - December 17, 2015, Sedgefield, United Kingdom - Kromek, a radiation detection technology company, announced non-executive directors Max Robinson, Brian Tanner, Charlotta Ginman and Peter Bains stepped down.
Article continues below
Mr. Robinson, Founder Director, provided business angel finance in order to establish Kromek. He is a respected academic and a pioneer, inventor in the field of 3-D x-ray imaging. He has been involved in the management of the interface between academic research and the commercialisation of its findings for 35 years.
Mr. Robinson currently holds the position of Entrepreneur in Residence at Newcastle University.
Mr. Tanner, Deputy Chairman and member of the Remuneration Committee, is Dean for University Enterprise and Professor of Physics at Durham University. With an international reputation in x-ray characterisation of materials, and in particular semiconductors, he has published over 375 papers in international peer-reviewed journals and is the author or co-author of 4 books.
Mr. Tanner received the Queen's Award for Enterprise Promotion (2012) and the Barrett Award of the International Center for Diffraction Data (2005). He holds, or has held, several directorships in addition to Kromek. He was a member of the governing council of Durham University for 15 years.
Ms. Ginman is a Director and Chairman of the Audit Committee. Joining Ernst & Young and later appointed to senior roles with JP Morgan, Deutsche Bank and UBS, she progressed to director of finance at Nokia Corporation.
A chartered accountant, Ms. Ginman also holds an MSc in Economics from the Swedish School of Economics and Business Administration in Helsinki.
Mr. Bains is a Director and member of the Audit Committee. During a 23-year career at GlaxoSmithKline, he held senior strategic and operational roles including General Manager of China, Head of Global Marketing and Senior VP of International Commercial Operations.
A consultant since 2009, Mr. Bains specialises in supporting strategic growth opportunities in small/medium-sized innovation-based life science companies serving as Non-Executive Director for Tokyo listed biotech company, Sosei; Biocon subsidiary, Syngene, and as Non-Executive Chairman of Fermenta Biotech Ltd.
Mr. Bains holds a BSc Combined Honours in Physiology/Zoology from Sheffield University. ■